Simulated modeling results now available for continuous distribution of kidney and pancreas
Report evaluates and compares several potential scenarios, will inform committees in their work.
Report evaluates and compares several potential scenarios, will inform committees in their work.
Beginning Jan. 1, 2023, this new benefit helps cover the costs for immunosuppressive drugs beyond 36 months after transplant for patients with ESRD.
We’ve put together some frequently asked questions to help patients wondering about the upcoming change.
This policy change is intended to more accurately reflect patient sensitization.
With the newly updated data, transplant programs can better understand how their Offer Filters would have affected the number of offers received recently.
Heather Marshall of Ascension Saint Thomas West Hospital on the education and peer support initiative her program helped pilot.